Back to Agenda
Session 2A: Control Strategy for Double-Stranded Oligonucleotides
Session Chair(s)
Samantha Gao-Sheridan, PhD
Senior Director, Regulatory Affairs CMC
Alnylam Pharmaceuticals, United States
Learning Objective :
Speaker(s)
European Regulatory Perspective on Double-Stranded Oligonucleotides
René Thürmer, PhD
Federal Institute for Drugs and Medical Devices, Germany
Deputy Head of the Unit Pharmaceutical Biotechnology BfArM
![Matthias Kretschmer, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Characterization and Control of siRNA Impurities
Matthias Kretschmer, PhD
Alnylam Pharmaceuticals, United States
Senior Director, Analytical Development
![Panel Discussion](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panel Discussion
All Session Speakers, United States
Panelist
Ramesh Raghavachari, PhD
FDA, United States
Chief, Branch I, DPMA1, OLDP, OPQ, CDER
![Vidhya Gopalakrishnan, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Panelist
Vidhya Gopalakrishnan, PhD
Quark Pharmaceuticals, Inc, United States
Senior Vice President, Pharmaceutical Development
Have an account?